Literature DB >> 2318085

Improved method for computing potential doubling time from flow cytometric data.

R A White1, N H Terry, M L Meistrich, D P Calkins.   

Abstract

Relative movement methods use the timed progression of the mean fluorescence of cells which have been labeled with monoclonal antibodies against bromodeoxyuridine and displayed with bivariate flow cytometry according to DNA and label content to compute duration of DNA synthesis, TS. The relative movement is the difference of the mean DNA fluorescence of the labeled undivided cells from the G1 channel relative to the difference between the G1 and G2M channels. In this communication, we show how to extend this method to compute the potential doubling time, Tpot, the time required for a population of cells to double, given quiescent cells but no cell loss. A quantity v is introduced that is a function of the fraction of labeled divided cells and the fraction of labeled undivided cells. We show that v is independent of time and is equal to ln(2)Ts/Tpot so that Tpot (equal to ln(2)Ts/v) can be directly found from the information available in computing the relative movement. The method is applied to Chinese hamster ovary cells to demonstrate its utility.

Entities:  

Mesh:

Year:  1990        PMID: 2318085     DOI: 10.1002/cyto.990110214

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  14 in total

1.  Human cytomegalovirus IE2 86-kilodalton protein binds p53 but does not abrogate G1 checkpoint function.

Authors:  L R Bonin; J K McDougall
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Upstream stimulatory factor regulates expression of the cell cycle-dependent cyclin B1 gene promoter.

Authors:  J P Cogswell; M M Godlevski; M Bonham; J Bisi; L Babiss
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

3.  Inhibition of human T-cell proliferation by mammalian target of rapamycin (mTOR) antagonists requires noncoding RNA growth-arrest-specific transcript 5 (GAS5).

Authors:  Mirna Mourtada-Maarabouni; Anwar M Hasan; Farzin Farzaneh; Gwyn T Williams
Journal:  Mol Pharmacol       Date:  2010-04-26       Impact factor: 4.436

4.  Mechanisms of G2 arrest in response to overexpression of p53.

Authors:  W R Taylor; S E DePrimo; A Agarwal; M L Agarwal; A H Schönthal; K S Katula; G R Stark
Journal:  Mol Biol Cell       Date:  1999-11       Impact factor: 4.138

5.  Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7.

Authors:  G W Demers; S A Foster; C L Halbert; D A Galloway
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

6.  Potential tumour doubling time: determination of Tpot for various canine and feline tumours.

Authors:  U Schwyn; N E Crompton; H Blattmann; B Hauser; B Klink; A Parvis; D Ruslander; B Kaser-Hotz
Journal:  Vet Res Commun       Date:  1998-06       Impact factor: 2.459

7.  The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest.

Authors:  S A Foster; G W Demers; B G Etscheid; D A Galloway
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

8.  Growth patterns and cell kinetics of human osteosarcoma xenografts in serial passages in nude mice analyzed by in vivo labelling with iododeoxyuridine.

Authors:  L A Broström; S Crnalic; R Löfvenberg; L Boquist; R Stenling
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

9.  Telomerase expression is sufficient for chromosomal integrity in cells lacking p53 dependent G1 checkpoint function.

Authors:  Dennis A Simpson; Elizabeth Livanos; Timothy P Heffernan; William K Kaufmann
Journal:  J Carcinog       Date:  2005-10-06

10.  An assessment of the reliability and reproducibility of measurement of potential doubling times (Tpot) in human colorectal cancers.

Authors:  M S Wilson; C M West; G D Wilson; S A Roberts; R D James; P F Schofield
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.